Dosidal · Poland
Natrium bicarbonicum 8,4% Polpharma
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Poland |
|---|---|
| Record | pl:presentation:6920 (version 1) |
| Level | presentation |
| Pack code | not anchored |
| Identifiers | rpl-pack-id: 6920 |
| Source authority | URPL |
| Read date | 2026-11-15T02:02:49Z |
| controlled status | availability_category: LzRp definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf narcotic_or_psychotropic: False state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| identity | atc: B05BB01 authorisation_number: 02485 deleted: True form: Roztwór do wstrzykiwań holder: Zakłady Farmaceutyczne POLPHARMA S.A. medicine: Natrium bicarbonicum 8,4% Polpharma pack_units: jednostkaPojemnosci: ml liczbaOpakowan: 1 pojemnosc: 20 rodzajOpakowania: amp. procedure: NAR routes: dożylna strength: 84 mg/ml substances: amount: 1,68 substance: Natrii hydrogenocarbonas unit: g state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| pack product code | state: unknown |
| prescription class | availability_category: LzRp definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf prescription: True state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53LNti314YjUS1RPkMcttKVqbVtxWhz_3ZnXNS0UkpCrpAUhLrZN_fBnoEWfrHm-6oCe4KxXe21AwFgDJMkzXspwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |